Provided by Tiger Trade Technology Pte. Ltd.

ORBUSNEICH

3.750
-0.080-2.09%
Volume:201.00K
Turnover:767.02K
Market Cap:3.10B
PE:9.41
High:3.840
Open:3.835
Low:3.750
Close:3.830
52wk High:4.950
52wk Low:3.349
Shares:828.00M
HK Float Shares:827.97M
Volume Ratio:4.22
T/O Rate:0.02%
Dividend:0.27
Dividend Rate:7.20%
EPS(LYR):0.398
ROE:10.57%
ROA:6.24%
PB:0.95
PE(LYR):9.41
PS:2.02

Loading ...

OrbusNeich Maintains Stable Share Capital in May 2026, Confirms Public Float Compliance

Bulletin Express
·
Jun 03

OrbusNeich posts zero share-capital movements in April; 11.78 million options remain outstanding

Bulletin Express
·
May 04

Solid Earnings May Not Tell The Whole Story For OrbusNeich Medical Group Holdings (HKG:6929)

Simply Wall St.
·
Apr 21

OrbusNeich releases 2025 Annual Report, AGM Circular and ESG Report; shifts fully to electronic communications

Bulletin Express
·
Apr 13

OrbusNeich Publishes FY-2025 Annual & ESG Reports, Confirms Full Transition to E-Communications

Bulletin Express
·
Apr 13

OrbusNeich Medical Group’s 2025 Results Show 10% Revenue Rise and Strengthened Financial Position

Bulletin Express
·
Apr 13

OrbusNeich Releases 2025 ESG Report: Lower Carbon Intensity, Wider Reporting Scope and Zero Workplace Injuries

Bulletin Express
·
Apr 13

OrbusNeich Schedules 8 June 2026 AGM; Board Seeks Shareholder Nod for HK$0.12 Dividend, Director Re-elections and New Mandates

Bulletin Express
·
Apr 13

ORBUSNEICH tables 2026 AGM agenda: HK $0.12 final dividend, mandates for 20% share issuance and 10% buy-back

Bulletin Express
·
Apr 13

OrbusNeich Medical Group Holdings announces annual shareholder meeting

Reuters
·
Apr 13

OrbusNeich Medical Group publishes 2025 ESG report

Reuters
·
Apr 13

OrbusNeich Medical Group Holdings publishes Annual Report 2025

Reuters
·
Apr 13

ORBUSNEICH Maintains Share Capital Stability in March 2026; 0.20 Million Pre-IPO Options Lapse

Bulletin Express
·
Apr 01

ORBUSNEICH's Target Price Lowered to HK$5.3 by CICC, Profitability Remains Broadly Stable

Stock News
·
Mar 16

OrbusNeich Medical Group (SEHK:6929) Net Margin Compression Tests Bullish Growth Narrative

Simply Wall St.
·
Mar 13

BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLN

Reuters
·
Mar 12

OrbusNeich Medical Posts Over 5% Rise in 2025 Profit

MT Newswires Live
·
Mar 12